Zobrazeno 1 - 10
of 13
pro vyhledávání: '"Camila Bragança Xavier"'
Publikováno v:
Journal of Immunotherapy and Precision Oncology, Vol 7, Iss 3, Pp 168-170 (2024)
Externí odkaz:
https://doaj.org/article/c0ae761a77e5466299d9bcbf150ef951
Autor:
Luciana Beatriz Mendes Gomes, Renata Lazari Sandoval, Camila Bragança Xavier, Tatiana Strava Correa, Raquel Midori Koga Matuda, Zenaide Silva de Souza, Luiz Guilherme Cernaglia Aureliano de Lima, Mariana Petaccia de Macedo, Filomena Marino Carvalho, Daniele Assad Suzuki
Publikováno v:
Case Reports in Oncology, Vol 17, Iss 1, Pp 1-9 (2024)
Malignant mixed müllerian tumor (MMMT) is a rare neoplasm, consisting of carcinomatous (epithelial) and sarcomatous (mesenchymal) components that most commonly arise in the endometrium and more infrequently in the ovaries, fallopian tube, cervix, an
Externí odkaz:
https://doaj.org/article/c7114bc99ed947dabb1548b4fbd062a6
Autor:
Mauricio Fernando Silva Almeida Ribeiro, Camila Bragança Xavier, Allan Andresson Lima Pereira, Mariana Scaranti, Luiza Dib Batista Bugiato Faria, Tatiana Strava Correa, Marina Sahade, David Queiroz Borges Muniz, Olavo Feher, Gustavo dos Santos Fernandes, Artur Katz, Rodrigo Ramella Munhoz
Publikováno v:
Brazilian Journal of Oncology, Vol 18, Iss 00 (2022)
Objectives: Immune-checkpoint inhibitors (ICI) and targeted-therapies (TT) have become standard options for BRAF-V600 metastatic melanomas (MM). Recently, randomized trials (RCT) addressed the efficacy of combined approaches, with conflicting results
Externí odkaz:
https://doaj.org/article/d8baab6b1db4491c84f2d3e64dbf6379
Autor:
Camila Bragança Xavier, Carlos Diego Holanda Lopes, Guilherme Harada, Eduardo Dante Bariani Peres, Artur Katz, Denis Leonardo Jardim
Publikováno v:
Translational Oncology, Vol 19, Iss , Pp 101383- (2022)
Background: Immune checkpoint inhibitors may be associated with multiple immune-related toxicities. Cardiovascular adverse effects are underreported in clinical trials. Methods: We conducted a systematic review and meta-analysis to evaluate cardiovas
Externí odkaz:
https://doaj.org/article/5833ecae73c347c9a1db3e2c771b7c03
Autor:
Aline Cristini Vieira, Camila Bragança Xavier, Thiago Dieb Vieira, Filomena Marino Carvalho, Mariana Scaranti, Rodrigo Ramela Munhoz, Jesus Paula Carvalho
Publikováno v:
Gynecologic Oncology Reports, Vol 36, Iss , Pp 100745- (2021)
Externí odkaz:
https://doaj.org/article/afe8b2b1c40544dd902ffb2e1f6b275b
Autor:
Eduardo Felicio Campos, Camila Bragança Xavier, Marcello Moro Queiroz, Nildevande Firmino Lima, Denis L. Jardim, Diogo Assed Bastos, Eder Nisi Ilario, Rafael Ferreira Coelho, William Carlos Nahas
Publikováno v:
Journal of Clinical Oncology. 41:341-341
341 Background: Several phase II trials have investigated neoadjuvant novel androgen receptor signaling inhibitors (ARSIs) in combination with androgen deprivation therapy (ADT) followed by radical prostatectomy (RP) in prostate cancer (PC) patients
Autor:
Zenaide Silva Souza, Camila Bragança Xavier, Luciana Beatriz Mendes Gomes Siqueira, Maria Fernanda Barbosa de Medeiros, Micelange Carvalho de Souza, Maria Dirlei de Souza Begnami, Allan Andresson Lima Pereira, José Flávio Gomes Marin, Carlos Alberto Buchpiguel, Frederico Costa
Publikováno v:
Journal of Clinical Oncology. 41:642-642
642 Background: GEP-NETs are the most common NETs primary site. Lu-177 is the standard treatment for patients with grade 1 (G1) or grade 2 (G2) midgut NETs who had disease progression during first-line somatostatin analog therapy. Methods: We perform
Autor:
Gustavo Dos Santos Fernandes, Tiago Biachi de Castria, Camila Bragança Xavier, Katia Regina Marchetti, Denis Leonardo Fontes Jardim
Publikováno v:
Journal of Gastrointestinal Cancer. 52:374-380
Over the last decades, cytotoxic chemotherapy has been the cornerstone of metastatic pancreatic adenocarcinoma treatment. In late-stage disease, a range of treatment regimens still offers minor benefits. Molecular profiling studies have shown that pa
Autor:
Camila Bragança Xavier, Carlos Diego Holanda Lopes, Guilherme Harada, Eduardo Dante Bariani Peres, Artur Katz, Denis Leonardo Jardim
Publikováno v:
Translational oncology. 19
Immune checkpoint inhibitors may be associated with multiple immune-related toxicities. Cardiovascular adverse effects are underreported in clinical trials.We conducted a systematic review and meta-analysis to evaluate cardiovascular adverse effects
Autor:
Camila Bragança Xavier, Gabriela Guardia, Carlos Diego Holanda Lopes, Beatriz Mendes Awni, Eduardo Felicio Campos, João Pedro Alves, Anamaria Aranha Camargo, Pedro Alexandre Favoretto Galante, Denis L. Jardim
Publikováno v:
Journal of Clinical Oncology. 40:2632-2632
2632 Background: High-TMB was recently approved as an agnostic biomarker for pembrolizumab in advanced cancers. Still, several patients with high-TMB do not respond to ICI, while some patients with low-TMB benefit from immunotherapy. Methods: We coll